Business Development Efforts are Guided by Clear Principles
Aptalis Pharma business development is focused on:
- Marketed or late-stage development products with significant efficacy data in GI conditions or Cystic Fibrosis
- Products or companies with sustainable competitive advantages such as
- Unique efficacy and safety profiles that address unmet medical needs
- Strong intellectual property protection
- Extended market exclusivity periods
- Proprietary manufacturing capabilities
